Steven Shia
Arcus Biosciences (United States) · 28 works · 1,622 citations · h-index 19
Top works
- A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies
- Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors
- Lead identification of novel and selective TYK2 inhibitors
- Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors
- Aspartate Isomerization in the Complementarity-Determining Regions of Two Closely Related Monoclonal Antibodies
- Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor
- Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2
- Conformational Lability in Serine Protease Active Sites: Structures of Hepatocyte Growth Factor Activator (HGFA) Alone and with the Inhibitory Domain from HGFA Inhibitor-1B
- Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2
- Structural insight into distinct mechanisms of protease inhibition by antibodies
- Unraveling the Allosteric Mechanism of Serine Protease Inhibition by an Antibody
- Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists
- Structure-guided enzymology of the lipid A acyltransferase LpxM reveals a dual activity mechanism
- Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2
- Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit
- Two Distinct Mechanisms of Inhibition of LpxA Acyltransferase Essential for Lipopolysaccharide Biosynthesis
- Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors
- Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model
- Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit
- Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitors